Sphingolipids, Dietary Fatty Acids, and Intestinal Pathophysiology
鞘脂、膳食脂肪酸和肠道病理生理学
基本信息
- 批准号:10338567
- 负责人:
- 金额:$ 33.21万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-12-01 至 2025-11-30
- 项目状态:未结题
- 来源:
- 关键词:ApoptosisAutophagocytosisBioinformaticsBiologyBiopsyCellular StressCeramidesColitisComplexCorn OilCoupledDataDietDietary Fatty AcidDiseaseEndoplasmic Reticulum Degradation PathwayEnzymesEpithelial CellsEventFatty AcidsFatty acid glycerol estersFish OilsFoodFunctional disorderGenerationsGenesGenetic TranscriptionGoalsHeart DiseasesHigh Fat DietIL6 geneInflammationInflammatory Bowel DiseasesInformaticsInositolInterleukin-10IntestinesLeadLinkLipidsLiteratureMediatingMediator of activation proteinMetabolic DiseasesMetabolismMilkModelingMolecular ChaperonesMusMyristatesNutritionalObesityOlive oil preparationOrganoidsPathway interactionsPatientsPhysiologyPlantsProcessProtein BiosynthesisProtein Synthesis InductionProteinsProteomicsPublishingRNA SplicingRegulationRoleSaturated Fatty AcidsSignal TransductionSourceSoybeansSphingolipidsStressTestingTissuesTrans FatsValidationXBP1 genearmbasedietarydihydroceramide desaturaseendoplasmic reticulum stressgut inflammationin vivoinnovationinsightintestinal epitheliumintestinal homeostasislardlipid mediatorlipid metabolismmilk fatmurine colitisnovelphosphoproteomicsresponsesaturated fattherapeutic target
项目摘要
Diets high in fat have been linked to obesity, and a high fat diet (HFD) has been implicated in altering intestinal function, including inflammation; however, the contribution of specific HFDs and their predominant fatty acids (FAs) on key pathophysiologic processes is largely unknown. Studies with trans-fats, lard, olive oil, fish oil, plant- based fats (corn oil, soybean, etc.) have demonstrated that specific sources of FAs exert extremely diverse effects in disease, most commonly in cardiac and metabolic disease. Therefore, the long-term goal of this proposal is to dissect the complexity of components and effects of specific dietary FAs on gut pathobiology and determine the mechanisms involved. Specifically, we aim to define the specific roles of two ceramide-generating enzymes, ceramide synthases (CerS) 5 and 6, in the regulation of myristate-induced activation of inositol requiring enzyme 1α (IRE1α) and define their critical roles in intestinal homeostasis and pathophysiology. IRE1α is a critical branch in the unfolded protein response (UPR) or ER stress and is an evolutionarily conserved signaling mechanism to overcome stress in the ER, resulting in a pause of new protein synthesis and induction of chaperone proteins to restore normal ER function. Functionally, ER stress and IRE1αv have been linked to alterations in intestinal homeostasis and inflammation. Specifically, ER stress genes are upregulated in intestinal epithelial cells (IECs) from a murine experimental colitis model (IL10-deficient)1 and in IECs or biopsies from inflammatory bowel disease (IBD) patients1,2. IRE1α, as well as other effectors of ER stress, can be initiated by several triggers including high fat diet (HFD) or treatment with saturated FAs, as well as exogenous and endogenous sphingolipids3-5. These important clues in the literature, together with our studies on bioactive sphingolipids in intestinal inflammation, led us to investigate the role of specific dietary FAs in sphingolipid metabolism and their role and mechanism(s) of action in intestinal ER stress. Our very novel observations demonstrate that the C14 saturated FA myristate (rich in milk based diets), but not palmitate (C16 saturated FA), increases ER stress, as well as inflammation in IECs in culture and in mouse intestinal tissues in vivo6. Mechanistically, ceramide synthases 5 and 6 (CerS 5 and 6) are required for the activation of IRE1α branch of the UPR, inducing splicing of XBP1 and expression of IL66. Importantly, these data now lead us to the hypothesis that CerS5/6 and the generation of C14 ceramide regulate IRE1α in the intestine and that this may mediate specific responses in intestinal pathobiology (specifically intestinal inflammation). To test this hypothesis, we propose the following specific aims: Specific Aim 1. Determine the role of CerS5/6 in the regulation of ER stress, specifically IRE1α, in intestinal epithelial cells and intestinal organoids. Specific Aim 2. Define the role of CerS5/6 in ER stress-mediated intestinal pathobiology in vivo.
高脂肪饮食与肥胖有关,高脂肪饮食 (HFD) 可能会改变肠道功能,包括炎症;然而,特定的 HFD 及其主要脂肪酸 (FA) 对关键病理生理过程的贡献在很大程度上是显着的。对反式脂肪、猪油、橄榄油、鱼油、植物性脂肪(玉米油、大豆等)的研究表明,特定来源的 FA 对疾病有极其不同的影响,最常见的是心脏病。因此,该提案的长期目标是剖析特定膳食 FA 的成分复杂性和对肠道病理生物学的影响,并确定所涉及的机制。具体来说,我们的目标是确定两种神经酰胺生成酶的具体作用。 、神经酰胺合酶 (CerS) 5 和 6,在调节肉豆蔻酸诱导的肌醇需要酶 1α (IRE1α) 的激活中,并确定它们在肠道稳态和IRE1α是未折叠蛋白反应(UPR)或内质网应激的一个关键分支,是一种进化上保守的信号机制,可以克服内质网应激,导致新蛋白合成暂停并诱导伴侣蛋白恢复正常内质网功能。从功能上讲,ER 应激和 IRE1αv 与肠道稳态和炎症的改变有关,具体来说,ER 应激基因在小鼠肠上皮细胞 (IEC) 中上调。实验性结肠炎模型(IL10 缺陷)1 和炎症性肠病 (IBD) 患者的 IEC 或活检中的 IRE1α 以及其他 ER 应激效应因子,可以由多种触发因素启动,包括高脂肪饮食 (HFD) 或用饱和 FA 以及外源性和内源性鞘脂进行治疗3-5 文献中的这些重要线索以及我们对生物活性鞘脂的研究。肠道炎症,促使我们研究特定膳食 FA 在鞘脂代谢中的作用及其在肠道 ER 应激中的作用和作用机制。我们非常新颖的观察结果表明,C14 饱和 FA 肉豆蔻酸酯(富含基于牛奶的饮食),但棕榈酸(C16 饱和 FA)会增加 ER 应激,以及培养物和小鼠体内肠道组织中的炎症 6。 CerS5/6(CerS 5 和 6)是激活 UPR IRE1α 分支、诱导 XBP1 剪接和 IL66 表达所必需的。重要的是,这些数据现在使我们得出这样的假设:CerS5/6 和 C14 神经酰胺的生成调节 IRE1α。为了检验这一假设,我们提出了以下具体目标: 1. 确定 CerS5/6 在肠上皮细胞和肠类器官中 ER 应激(特别是 IRE1α)调节中的作用 具体目标 2. 确定 CerS5/6 在 ER 应激介导的体内肠道病理学中的作用。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Ashley J. Snider其他文献
Ashley J. Snider的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Ashley J. Snider', 18)}}的其他基金
Role for myeloid acid ceramidase in colon inflammation and cancer
髓样酸性神经酰胺酶在结肠炎症和癌症中的作用
- 批准号:
10418031 - 财政年份:2022
- 资助金额:
$ 33.21万 - 项目类别:
Role for myeloid acid ceramidase in colon inflammation and cancer
髓样酸性神经酰胺酶在结肠炎症和癌症中的作用
- 批准号:
10593982 - 财政年份:2022
- 资助金额:
$ 33.21万 - 项目类别:
Sphingolipids, Dietary Fatty Acids, and Intestinal Pathophysiology
鞘脂、膳食脂肪酸和肠道病理生理学
- 批准号:
10532716 - 财政年份:2021
- 资助金额:
$ 33.21万 - 项目类别:
Developing animal models to dissociate lysosomal from inflammatory functions of acid sphingomyelinase
开发动物模型以将溶酶体与酸性鞘磷脂酶的炎症功能分离
- 批准号:
9975866 - 财政年份:2020
- 资助金额:
$ 33.21万 - 项目类别:
Developing animal models to dissociate lysosomal from inflammatory functions of acid sphingomyelinase
开发动物模型以将溶酶体与酸性鞘磷脂酶的炎症功能分离
- 批准号:
10133427 - 财政年份:2020
- 资助金额:
$ 33.21万 - 项目类别:
Developing animal models to dissociate lysosomal from inflammatory functions of acid sphingomyelinase
开发动物模型以将溶酶体与酸性鞘磷脂酶的炎症功能分离
- 批准号:
9806440 - 财政年份:2019
- 资助金额:
$ 33.21万 - 项目类别:
The Role of Sphingolipids in Inflammatory Bowel Disease
鞘脂在炎症性肠病中的作用
- 批准号:
7749790 - 财政年份:2009
- 资助金额:
$ 33.21万 - 项目类别:
Core C: Sphingolipid Cancer Animal Pathology Core
核心 C:鞘脂癌症动物病理学核心
- 批准号:
10020946 - 财政年份:2003
- 资助金额:
$ 33.21万 - 项目类别:
相似国自然基金
FAM134B介导内质网自噬对脓毒症状态下树突状细胞铁死亡的调节作用及信号机制
- 批准号:82302412
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
PRDX6增强铁蛋白稳定性抑制铁自噬减轻慢阻肺上皮细胞铁死亡的作用及机制研究
- 批准号:82370048
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
lncRNA MEG3在电针调控自噬抑制肌腱干细胞衰老中的作用及机制研究
- 批准号:82374558
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
基于SENP1-Sirt3介导ISCs线粒体自噬探讨GL-V9治疗放射性肠损伤的作用及机制研究
- 批准号:82304595
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
靶向MCL-1诱导线粒体自噬探讨五味子叶治疗AD三萜类药效物质基础及作用机制
- 批准号:82374007
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
BCCMA: Overcoming chemoresistance in ovarian cancer: Identification and validation of biomarkers and targetable drivers of platinum resistance
BCCMA:克服卵巢癌的化疗耐药性:铂类耐药的生物标志物和靶向驱动因素的识别和验证
- 批准号:
10585641 - 财政年份:2023
- 资助金额:
$ 33.21万 - 项目类别:
Sphingolipids, Dietary Fatty Acids, and Intestinal Pathophysiology
鞘脂、膳食脂肪酸和肠道病理生理学
- 批准号:
10532716 - 财政年份:2021
- 资助金额:
$ 33.21万 - 项目类别:
Elucidating structural, mechanistic, and allosteric determinants of mTOR Complex 2 (mTORC2) signaling.
阐明 mTOR 复合物 2 (mTORC2) 信号传导的结构、机制和变构决定因素。
- 批准号:
10284076 - 财政年份:2021
- 资助金额:
$ 33.21万 - 项目类别:
Gold-derived therapeutic compounds for disease application
用于疾病应用的金衍生治疗化合物
- 批准号:
10180196 - 财政年份:2021
- 资助金额:
$ 33.21万 - 项目类别:
Gold-derived therapeutic compounds for disease application
用于疾病应用的金衍生治疗化合物
- 批准号:
10461752 - 财政年份:2021
- 资助金额:
$ 33.21万 - 项目类别: